BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25280656)

  • 1. Open versus needle biopsy in diagnosing neuroblastoma.
    Mullassery D; Sharma V; Salim A; Jawaid WB; Pizer BL; Abernethy LJ; Losty PD
    J Pediatr Surg; 2014 Oct; 49(10):1505-7. PubMed ID: 25280656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children.
    Hassan SF; Mathur S; Magliaro TJ; Larimer EL; Ferrell LB; Vasudevan SA; Patterson DM; Louis CU; Russell HV; Nuchtern JG; Kim ES
    J Pediatr Surg; 2012 Jun; 47(6):1261-6. PubMed ID: 22703803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of needle versus open biopsy for the diagnosis of advanced stage pediatric neuroblastoma.
    Gupta A; Kumar A; Walters S; Chait P; Irwin MS; Gerstle JT
    Pediatr Blood Cancer; 2006 Dec; 47(7):875-9. PubMed ID: 16276526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
    London WB; Castleberry RP; Matthay KK; Look AT; Seeger RC; Shimada H; Thorner P; Brodeur G; Maris JM; Reynolds CP; Cohn SL
    J Clin Oncol; 2005 Sep; 23(27):6459-65. PubMed ID: 16116153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Video-Assisted Needle Core Biopsy in Children Affected by Neuroblastoma: A Novel Combined Technique.
    Avanzini S; Faticato MG; Sementa AR; Granata C; Martucciello G; Pio L; Prato AP; Garaventa A; Bisio G; Montobbio G; Buffa P; Mattioli G
    Eur J Pediatr Surg; 2017 Apr; 27(2):166-170. PubMed ID: 27019147
    [No Abstract]   [Full Text] [Related]  

  • 6. Percutaneous biopsy for prognostic testing of neuroblastoma.
    Hoffer FA; Chung T; Diller L; Kozakewich H; Fletcher JA; Shamberger RC
    Radiology; 1996 Jul; 200(1):213-6. PubMed ID: 8657913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
    Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
    Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of percutaneous biopsy for diagnosis and pretreatment risk assessment of neuroblastoma.
    Overman RE; Kartal TT; Cunningham AJ; Fialkowski EA; Naik-Mathuria BJ; Vasudevan SA; Malek MM; Kalsi R; Le HD; Stafford LC; Lautz TB; Many BT; Jones RE; Bütter A; Davidson J; Williams A; Dasgupta R; Lewis J; Troutt M; Aldrink JH; Mansfield SA; Lal DR; Xiao J; Meyers RL; Short SS; Newman EA
    Pediatr Blood Cancer; 2020 May; 67(5):e28153. PubMed ID: 32072730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous image-guided needle biopsy in children--summary of our experience with 57 children.
    Sklair-Levy M; Lebensart PD; Applbaum YH; Ramu N; Freeman A; Gozal D; Gross E; Sherman Y; Bar-Ziv J; Libson E
    Pediatr Radiol; 2001 Oct; 31(10):732-6. PubMed ID: 11685444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children.
    Fröstad B; Martinsson T; Tani E; Falkmer U; Darnfors C; Skoog L; Kogner P
    Cancer; 1999 Apr; 87(2):60-8. PubMed ID: 10227595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease.
    Mora J; Cheung NK; Chen L; Qin J; Gerald W
    Cancer; 2001 Jan; 91(2):435-42. PubMed ID: 11180092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive polymerase chain reaction for the determination of N-myc amplification in neuroblastoma: report of clinical cases.
    Hasan Z; Inoue A; Ikeda H; Kamii Y; Obana K; Yokomori K; Tsuchida Y; Hemmi H; Shimatake H
    Eur J Pediatr Surg; 1999 Jun; 9(3):138-41. PubMed ID: 10427487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes in children with adrenal neuroblastoma undergoing open versus laparoscopic adrenalectomy.
    Kelleher CM; Smithson L; Nguyen LL; Casadiego G; Nasr A; Irwin MS; Gerstle JT
    J Pediatr Surg; 2013 Aug; 48(8):1727-32. PubMed ID: 23932613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-myc gene amplification in neuroblastoma: a clinical approach using ultrasound guided cutting needle biopsies collected at diagnosis.
    Hedborg F; Lindgren PG; Johansson I; Kogner P; Samuelsson BO; Bekassy AN; Olsen L; Kreuger A; Påhlman S
    Med Pediatr Oncol; 1992; 20(4):292-300. PubMed ID: 1608350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.
    Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; O'Meara A; Ryan E; Catchpoole D; Breatnach F
    Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore.
    Yong MH; Hwang WS; Knight LA; Fung W; Chan MY; Seow WT; Chui CH
    Singapore Med J; 2009 Nov; 50(11):1090-4. PubMed ID: 19960166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification.
    Souzaki R; Tajiri T; Teshiba R; Kinoshita Y; Yosue R; Kohashi K; Oda Y; Taguchi T
    J Pediatr Surg; 2011 Dec; 46(12):2228-32. PubMed ID: 22152855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroblastoma: a 20-year experience in a UK regional centre.
    Salim A; Mullassery D; Pizer B; McDowell HP; Losty PD
    Pediatr Blood Cancer; 2011 Dec; 57(7):1254-60. PubMed ID: 21523901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.